Evaluation of optical coherence tomography findings in age-related macular degeneration: A reproducibility study of two independent reading centres

British Journal of Ophthalmology

Volumn 95, Issue 3, 2011, Pages 381-385

  Ritter, Markus ^a   Elledge, Julee ^b   Simader, Christian ^a   Deak, Gabor G ^a   Benesch, Thomas ^a   Blodi, Barbara A ^b   Schmidt Erfurth, Ursula M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONSENSUS; FEMALE; HEALTH CARE FACILITY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REPEAT PROCEDURE; REPRODUCIBILITY; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; SUBRETINAL FLUID; VITREOMACULAR TRACTION; VITREOUS DISEASE;

AGED; ANALYSIS OF VARIANCE; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; OBSERVER VARIATION; READING; REPRODUCIBILITY OF RESULTS; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 79952019651     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.175976     Document Type: Article

References (17)

1. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995;102:217-29.
2. Baumal CR. Clinical applications of optical coherence tomography. Curr Opin Ophthalmol 1999;10:182-8. (Pubitemid 29263942)
3. Rivellese M, George A, Sulkes D, et al. Optical coherence tomography after laser photocoagulation for clinically significant macular edema. Ophthalmic Surg Lasers 2000;31:192-7. (Pubitemid 30396774)
4. Panozzo G, Gusson E, Parolini B, et al. Role of OCT in the diagnosis and follow up of diabetic macular edema. Semin Ophthalmol 2003;18:74-81. (Pubitemid 37108396)
5. Massin P, Duguid G, Erginay A, et al. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 2003;135:169-77. (Pubitemid 36151793)
6. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103:1260-70. (Pubitemid 26282510)
7. Rogers AH, Martidis A, Greenberg PB, et al. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 2002;134:566-76. (Pubitemid 35304647)
8. Schmidt-Erfurth UM, Richard G, Augustin A, et al. European Society for Retina Specialists' Guidelines Committee (EURETINA).Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand 2007;85:486-94.
9. Zhang N, Hoffmeyer GC, Young ES, et al. Optical coherence tomography reader agreement in neovascular age-related macular degeneration. Am J Ophthalmol 2007;144:37-44.
10. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;159-74. (Pubitemid 8054849)
11. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable-dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-83.
12. Schlingemann RO, Schmidt-Erfurth U, Eldem B. and on behalf of the EXCITE study group. Safety and efficacy of quarterly vs. monthly ranibizumab injections in patients with neovascular age-related macular degeneration: 12-months results of the EXCITE study. Invest Ophthalmol Vis Sci 2009;50:E-Abstract 2382.
13. Holz FG, Meyer C, Eter N. and on behalf of the SUSTAIN study group. Safety and efficacy of ranibizumab treatment in patients with neovascular age-related macular degeneration: 12-month results of the SUSTAIN study. Invest Ophthalmol Vis Sci 2009;50:E-Abstract 3095.
14. Hubbard LD, Ricks MO, Martin BK. Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression. Am J Ophthalmol 2004;137:426-34. (Pubitemid 38328632)
15. Scott IU, Bressler NM, Bressler SB, et al. Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema. Retina 2008;28:36-40.
16. Domalpally A, Danis RP, Zhang B, et al. Quality issues in interpretation of optical coherence tomograms in macular diseases. Retina 2009;29:775-81.
17. Diabetic Retinopathy Clinical Research Network, Krzystolik MG, Strauber SF, Aiello LP, et al. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 2007;114:1520-5.